Contrast-Enhanced Spectral Mammography (CESM) is a recently introduced mammographic method with characteristics particularly suitable for breast cancer radiomic analysis. This work aims to evaluate radiomic features for predicting histological outcome and two cancer molecular subtypes, namely Human Epidermal growth factor Receptor 2 (HER2)-positive and triple-negative. From 52 patients, 68 lesions were identified and confirmed on histological examination. Radiomic analysis was performed on regions of interest (ROIs) selected from both low-energy (LE) and ReCombined (RC) CESM images. Fourteen statistical features were extracted from each ROI. Expression of estrogen receptor (ER) was significantly correlated with variation coefficient and variation range calculated on both LE and RC images; progesterone receptor (PR) with skewness index calculated on LE images; and Ki67 with variation coefficient, variation range, entropy and relative smoothness indices calculated on RC images. HER2 was significantly associated with relative smoothness calculated on LE images, and grading tumor with variation coefficient, entropy and relative smoothness calculated on RC images. Encouraging results for differentiation between ER+/ER−, PR+/PR−, HER2+/HER2−, Ki67+/Ki67−, High-Grade/Low-Grade and TN/NTN were obtained. Specifically, the highest performances were obtained for discriminating HER2+/HER2− (90.87%), ER+/ER− (83.79%) and Ki67+/Ki67− (84.80%). Our results suggest an interesting role for radiomics in CESM to predict histological outcomes and particular tumors’ molecular subtype.
Seasonal changes of testicular activity of the swordfish Xiphias gladius and correlations of plasma levels of testosterone (T) and 11‐ketotestosterone (11‐KT) with proliferation and apoptosis of germ cells, determined, respectively, with monoclonal antibodies against proliferating cell nuclear antigen and terminal deoxynucleotidyl transferase‐mediated d’UTP nick end labelling, are described. Three phases of the reproductive cycle were found: active spermatogenic (May), spawning (June to July) and spent (August to September) stages. Germ cell proliferating activity was highest in May, decreased during June to July and remained stable during August to September. Apoptotic germ cells, primary spermatocytes and spermatogonia, were present in all the specimens analysed and were more abundant in May. The levels of 11‐KT in plasma were always higher than T and were highest in May, in concomitance with the maximum proliferation and apoptosis rate of germ cells.
The presence of clusters of microcalcifications is a primary sign of breast cancer. Their identification is still difficult today for radiologists, and the wrong evaluations involve unnecessary biopsies. In this paper, an automatic tool for characterizing and discriminating clusters of microcalcifications into benign/malignant in digital mammograms is proposed. A set of 104 digital mammograms including microcalcification clusters was randomly extracted from a public available database and manually labeled by our radiologists, obtaining 96 abnormal ROIs. For each so-identified ROI, a multi-scale image decomposition based on the Haar wavelet transform was performed. On the decomposition, a textural features extraction step was carried out both on each sub-image and on the corresponding gray-level co-occurrence matrix. Then, a random forest classifier was employed for classifying microcalcification clusters into benign and malignant. The study found that the most discriminant features extracted from the ROIs decomposition by Haar transform were variance and relative smoothness, whereas as regards the textural features calculated on the GLCMs corresponding to the Haar-decomposed ROI, it emerged that the relationship between the pixels of the sub-image in the diagonal direction had high discriminating power for the classification of microcalcification clusters into benign and malignant. The proposed method was evaluated in cross-validation and performed highly in the prediction of the benign/malignant ROIs, with a mean AUC value of 97.39 ± 0.01 % .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.